【摘要】 目的：构建高血压、糖尿病“两病”门诊用药保障机制评估指标体系，为相关部门进行“两病”门诊用药保障机制评估工作提供参考。方法：本研究基于从事前评估、过程评估到效果评估的全过程评估方式，结合文献研究和专家访谈，开展三轮德尔菲专家咨询确定最终指标体系。结果：研究共咨询专家25人，经三轮德尔菲专家咨询后确定纳入一级指标3个，二级指标10个，三级指标24个。其中，一级指标及其权重分别为政策制定(0.236)、政策执行(0.481)和政策成效(0.283)。本研究中三轮德尔菲专家咨询的积极系数均为100%,权威系数为0.89,且专家协调程度逐轮提升。结论：构建的指标体系具有较高的科学性与稳定性，能够为“两病”门诊用药保障机制评估工作提供有效的评估工具。更多还原

【Abstract】 Objective: To construct an evaluation indicator system of the outpatient medication guarantee mechanism for hypertension and diabetes, and to provide reference to relevant departments for assessing this mechanism. Methods: This research reaches a final version of indicator system after three rounds of Delphi expert consultation with whole process evaluation method, which covers document evaluation, process evaluation to effect evaluation, and literature review as well as expert interviews. Results: 3 first-level indicators, 10 second-level indicators, and 24 third-level indicators are included after three rounds of Delphi expert consultation concerning 25 experts.Among them, the first-level indicators include policy formulation, policy implementation and policy effectiveness, with their weights being 0.236, 0.481 and 0.283. Positive factor of the research in the three rounds of Delphi expert consultation is 100%, and the authority factor is 0.89.Besides, expert coordination ascends round by round. Conclusion: The indicator system constructed by the research has fairly high scientific sense and stability, and can provide an effective assessment tool for the evaluation of the outpatient medication guarantee mechanism of hypertension and diabetes.更多还原